Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons

Cell Death and Differentiation

Volumn 17, Issue 9, 2010, Pages 1501-1510

  Kurnellas, M P ^a   Li, H ^a   Jain, M R ^a   Giraud, S N ^b   Nicot, A B ^b,c   Ratnayake, A ^a   Heary, R F ^a   Elkabes, S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b SORBONNE UNIVERSITÉ   (France)

^c Institut National de la Recherche   (France)

Author keywords

ATP2B2; excitotoxicity; multiple sclerosis; neuroprotection; spinal cord injury

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; KAINIC ACID RECEPTOR; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD NERVE CELL;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; EMBRYO, MAMMALIAN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; KAINIC ACID; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; PROTEOME; PROTEOMICS; QUINOXALINES; RATS; RATS, INBRED STRAINS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RNA, SMALL INTERFERING; SPINAL CORD;

ANIMALIA;

EID: 77955714077     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.54     Document Type: Article

References (40)

1. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-399.
2. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
3. Filippi M, Bozzali M, Rovaris M, Gonen O, Kesavadas C, Ghezzi A et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003; 126: 433-437.
4. Arnold DL. Magnetic resonance spectroscopy: imaging axonal damage in MS. J Neuroimmunol 1999; 98: 2-6.
5. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-1477.
6. Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252: 16-24.
7. Kuhlmann T, Lingfield G, Bitsch A, Schurchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002; 125: 2202-2212.
8. Nicot A, Ratnakar PV, Ron Y, Chen CC, Elkabes S. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 2003; 126: 398-412.
9. Nicot A, Kurnellas M, Elkabes S. Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis. Eur J Neurol 2005; 21: 2660-2670.
10. Kurnellas MP, Nicot A, Shull GE, Elkabes S. Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J 2005; 19: 298-300.
11. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 2001; 81: 21-50.
12. Garcia ML, Strehler EE. Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function. Front Biosci 1999; 4: D869-D882.
13. 2+-ATPase isoform 2. J Biol Chem 1998; 273: 18693-18696.
14. 2+-ATPase gene cause deafness in deafwaddler mice. Nat Genet 1998; 19: 390-394.
15. Kurnellas MP, Lee AK, Li H, Deng L, Ehrlich DJ, Elkabes S. Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neurons. Mol Cell Neurosci 2007; 34: 178-188.
16. Souayah N, Sharovetskaya A, Kurnellas MP, Myerson M, Deitch JS, Elkabes S. Reductions in motor unit number estimates (MUNE) precede motor neuron loss in the plasma membrane calcium ATPase 2 (PMCA2)-heterozygous mice. Exp Neurol 2008; 214: 341-346.
17. Wang LH, Strittmatter SM. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem 1997; 69: 2261-2269.
18. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 2003; 28: 51-64.
19. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000; 6: 67-70.
20. Kanwar JR, Kanwar RK, Krissansen GW. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004; 127: 1313-1331.
21. Shields DC, Schaecher KE, Saido TC, Banik NL. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci USA 1999; 96: 11486-11491.
22. Rami A, Ferger D, Krieglstein J. Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res 1997; 27: 93-97.
23. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005; 128: 1016-1025.
24. Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V. Excitatory amino acids and multiple sclerosis. Arch Neurol 2003; 60: 1082-1088.
25. Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001; 50: 169-180.
26. Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GV et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007; 66: 732-739.
27. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000; 6: 62-66.
28. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neurosci 1993; 53: 327-358.
29. Eriksson C, Tehranian R, Iverfeldt K, Winblad B, Schultzberg M. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J Neurosci Res 2000; 60: 266-279.
30. Corona JC, Tapia R. Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo. Neurochem Res 2008; 33: 1428-1434.
31. 2+ pump: focus on calpain sensitivity. J Biol Chem 2003; 278: 38141-38148.
32. 2+ pump activity in rat hippocampal neurons. J Neurochem 2006; 98: 1646-1656.
33. Shields DC, Banik NL. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination. Brain Res 1998; 794: 68-74.
34. Hassen GW, Feliberti J, Kesner L, Stracher A, Mokhtarian F. Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain Res 2008; 1236: 206-215.
35. Momeni HR, Azadi S, Kanje M. Calpain activation and apoptosis in motor neurons of cultured adult mouse spinal cord. Funct Neurol 2007; 22: 105-110.
36. Kieran D, Greensmith L. Inhibition of calpains, by treatment with leupeptin, improves motoneuron survival and muscle function in models of motoneuron degeneration. Neuroscience 2004; 125: 427-439.
37. Fukuta Y, Itoh TJ, Kimura T, Menager C, Nishimura T, Shiromizu T et al. CMRP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 2002; 4: 583-591.
38. Yuasa-Kawada J, Suzuki R, Kano F, Ohkawara T, Murata M, Noda M. Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur J Neurosci 2003; 17: 2329-2343.
39. Quach TT, Duchemin AM, Rogemond V, Aguera M, Honnorat J, Belin MF et al. Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons. Mol Cell Neurosci 2004; 25: 433-443.
40. Tachibana T, Noguchi K, Ruda MA. Analysis of gene expression following spinal cord injury in rat using complementary DNA microarray. Neurosci Lett 2002; 327: 133-137.